Inhaled nitric oxide for hypoxemic respiratory failure of the newborn

Respiratory Care

Volumn 44, Issue 2, 1999, Pages 169-173

  Roberts Jr , Jesse D ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute respiratory distress syndrome; Acute respiratory failure; Adverse effects; ARDS; Inhaled nitric oxide; Neonatology; Nitric oxide; NO; Pediatrics; Persistent pulmonary hypertension; Pulmonary

Indexed keywords

NITRIC OXIDE;

ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; DRUG MECHANISM; DRUG SAFETY; EXTRACORPOREAL OXYGENATION; HUMAN; HYPOXEMIA; INHALATION ANESTHESIA; LUNG INJURY; NEWBORN; NEWBORN HYPOXIA; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0032964474     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, Rudolph AM. Persistent pulmonary hypertension of the newborn infant. J Pediatr 1976;89(4):626-630.
2. Reid LM. Constrictive and restrictive pulmonary hypertension in the newborn and infant (review). Am J Cardiovasc Pathol 1987;1(2): 287-299
3. Haworth SG, Reid L. Persistent fetal circulation: newly recognized structural features. J Pediatrics 1976;88(4 Pt 1):614-620.
4. Geggel RL, Reid LM. The structural basis of PPHN (review). Clin Perinatol 1984;11(3):525-549.
5. Roberts JD Jr. Shaul PW. Advances in the treatment of persistent pulmonary hypertension of the newborn (review). Pediatr Clin North Am 1993;40(5) 983-1004.
6. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM, Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83(6):2038-2047.
7. Roberts JD Jr, Chen TY, Kawai N, Wain J, Dupuy P, Shimouchi A. et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb Circ Res 1993;72(2).246-254.
8. Zayek M, Cleveland D, Morin FC 3rd. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J Pediatr 1993;122(5 Pt 1):743-750
9. Zayek M, Wild L, Roberts JD Jr, Morin FC 3rd. Effect of nitric oxide on the survival rate and incidence of lung injury in newborn Iambs with persistent pulmonary hypertension. J Pediatr 1993;123(6):947-952.
10. Berger JI, Gibson RL, Redding GJ, Standaert TA, Clarke WR, Truog WE. Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis 1993;147(5).1080-1086.
11. Barrington KJ, Finer NN, Peliowski A, Etches PC, Graham AJ, Chan WK. Inhaled nitric oxide improves oxygenation in piglets with meconium aspiration Pediatr Pulmonol 1995,20(1).27-33.
12. Karamanoukian HL, Glick PL, Zayek M, Steinhorn RH, Zwass MS, Fineman JR, Morin FC 3rd. Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics 1994;94(5):715-718.
13. Wilcox DT, Glick PL, Karamanoukian HL, Morin FC 3rd, Fuhrman BP, Leach C. Partial liquid ventilation and nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg 1997;32(8).1211-1215.
14. Rovira I, Chen TY, Winkler M, Kawai N, Bloch KD, Zapol WM. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J App Physiol 1994;76(1): 345-355.
15. Krause MF, Lienhart HG, Haberstroh J, Hoehn T, Schulte-Monting J, Leititis JU. Effect of inhaled nitric oxide on intrapulmonary right-to-left-shunting in two rabbit models of saline lavage induced surfactant deficiency and meconium instillation. Eur J Pediatr 1998; 157(5):410-415.
16. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340(8823):818-819.
17. Kinsella JP, McQueston JA, Rosenberg AA, Abman SH. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am J Physiol 1992;263(3 Pt 2):H875-H880.
18. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994;124(2):302-308.
19. Roberts JD Jr, Fineman JR, Morin FC 3rd, Shaul PW, Rimar S, Schreiber MD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336(9):605-610.
20. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study The 1-NO/PPHN Study Group. Pediatrics 1998;101(3 Pt 1): 325-334.
21. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, et al. Randomized. multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997;131(1 Pt 1):55-62
22. The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336(9):597-604.
23. Crawley DE, Zhao L, Giembycz MA, Liu S, Barnes PJ, Winter RJD, Evans TW. Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am J Physiol 1992; 263(3 Pt 1):L323-L332.
24. Steinhorn RH, Russell JA, Morin FC 3rd. Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension. Am J Physiol 1995;268(4 Pt 2):H1483-H1489.
25. McQueston JA, Kinsella JP, Ivy DD, McMurtry IF, Abman SH. Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation. Am J Physiol 1995,268(1 Pt 2):H288-H294.
26. Ichinose F, Adrie C, Hurford WE, Zapol WM Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zapnnast in awake lambs J App Physiol 1995;78(2):1288-1295.
27. Ichinose F, Adrie C, Hurford WE, Bloch KD, Zapol WM. Selective pulmonary vasodilation induced by aerosolized zaprinast. Anesthesiology 1998;88(2):410-6.
28. Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH. Dipyridamole augmentation of response to nitric oxide (letter). Lancet 1995; 346(8975):647-648
29. Kinsella JP, Abman SH. High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn Nitric Oxide Study Group. Chest 1998; 114(1 Suppl):100S.
30. The Neonatal Inhaled Nitric Oxide Study Group (NLMOS). Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997;99(6):838-845.
31. Reid L. The lung growth and remodeling in health and disease Am J Roentgenol 1977;129.777-788
32. Hislop A, Reid L. Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension. Br J Exp Pathol 1977;58:653-662
33. Meyrick B, Reid L The effect of continued hypoxia on rat pulmonary arterial circulation An ultrastructural study Lab Invest 1978; 38(2):188-200.
34. Rabinovitch M, Gamble WJ, Nadas AS, Miettinen OS, Reid L. Rat pulmonary eirculation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 1979,236(6).H818-H827.
35. Kouyoumdjian C, Adnot S, Levame M, Eddahibi S, Bousbaa H, Raffestin B. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest 1994,94(2):578-584
36. Roberts JD Jr, Roberts CT, Jones RC, Zapol WM, Bloch KD. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res 1995;76(2):215-222.
37. Kourembanas S, McQuillan LP, Leung GK, Foller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993;92(1) 99-104.
38. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83(5):1774-1777.
39. Garg UC, Hassid A. Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur J Pharmacol 1993;237(2-3).243-249.
40. Roberts JD Jr, Chiche JD, Weimann J, Steudel W, Zapol WM, Bloch KD Inhaled nitric oxide gas (NO) prevents pulmonary artery neomuscularization in rat pups without pulmonary artery hypertension. Circulation 1998;I-341.
41. Todd L, Mullen M, Olley PM, Rabinovitch M. Pulmonary toxictiy of monocrotaline differs at critical periods of lung development. Pediatr Res 1985;19(7):731-737.
42. Maruyama J, Maruyama K, Mitani Y, Kitabatake M, Yamauchi T, Miyasaka K. Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats. Am J Physiol 1997;272(1 Pt 2):H517-524.
43. Horstman DJ, Frank DU, Rich GF. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats. Anesth Analg 1998;86(1):74-81.
44. Mitani Y, Maruyama K, Sakurai M. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 1997;96(2):689-697.
45. Takahashi T, Kanda T, Inoue M, Suzuki T, Kobayashi I, Kodama K, Naeai R, A selective type V phosphodiesterase inhibitor. E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension. Life Sci 1996;59(23):PL371-377.
46. Clutton-Brock J, Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anesthesia. Br J Anaesth 1967;39(5):388-392.
47. Hallman M, Bry K, Turbow R, Waffam F, Lappalainen U. Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure. J Pediatr 1998;132(5):827-829.
48. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 1997;41(4 Pt 1):457-463.
49. George TN, Johnson KJ, Bates JN, Segar JL. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998;132(4):731-734.
50. Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielh FM, et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr 1997;131(1 Pt 1):70-75.